Trial Profile
Safety and efficacy of Blinatumomab in adults with Relapsed/refractory B-precursor Acute Lymphoblastic Leukemia (ALL): The Bologna Compassionate Program
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 15 Jun 2019
Price :
$35
*
At a glance
- Drugs Blinatumomab (Primary)
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions; Expanded access; Therapeutic Use
- 04 Jun 2019 Results presented at the 55th Annual Meeting of the American Society of Clinical Oncology
- 03 Apr 2019 Results assessing efficacy and safety of Blinatumomab in B-ALL patients presented at the 110th Annual Meeting of the American Association for Cancer Research
- 17 Jan 2017 New trial record